Tuesday, 5 November 2013

Drug pricing challenges diabetes king Novo Nordisk

By Ben Hirschler and Mette Fraende COPENHAGEN (Reuters) - Drug pricing is emerging as a key challenge for Novo Nordisk, the world's biggest insulin producer, whose previously unstoppable growth has started to flag, according to the Danish fir...

Source: http://health.yahoo.net/news/s/nm/drug-pricing-challenges-diabetes-king-novo-nordisk

website view view site view website

No comments:

Post a Comment

Note: only a member of this blog may post a comment.